Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inmune Bio, Inc.

Common Size Income Statement

Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K
Revenues  100.0%  
Cost of goods sold  0.0%  
Gross profit  100.0%  
Research and development  35.3%  
General and administrative  64.7%  
EBIT  -83.4%  
Pre-tax income  -82.6%  
Income taxes  0.0%  
Net income  -82.6%  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy